Sahajanand Medical Technologies Ltd IPO

About Sahajanand Medical Technologies Ltd

The company is a engaged in the development of Class III1 and Class C/D2 medical devices, with an emphasis on Vascular Intervention (VI) and Structural Heart (SH). Its portfolio of (i) VI products includes coronary intervention products such as coronary stents and coronary balloons, (ii) SH products includes Trans-Catheter Aortic Valves and Occluders, and (iii) other products including the company own brand of renal stents, peripheral drug coated balloons and other trading products.

Sahajanand Medical Technologies Ltd IPO Timeline

Track key IPO dates — from opening and closing to allotment, refund, and listing.

Sahajanand Medical Technologies Ltd IPO Subscription Status

See how the issue is being subscribed across QIB, NII, Retail, and Employee categories.

A quick look at revenue, EBITDA, profit, and net worth over the last three years.

Sahajanand Medical Technologies Ltd IPO Strengths

• Technologically advanced products in segments with high entry barriers.
• Proven research and development capabilities across products categories and platform technologies.
• Leadership in India and key international markets across products.
• Deep global sales and marketing presence leading to fast growth in diversified international markets.
• Diversified, integrated, and efficient manufacturing facilities accredited by regulatory authorities.
• Proven M&A and strategic collaborations playbook
• Experienced leadership team backed by reputed institutional investors

Sahajanand Medical Technologies Ltd IPO Reservation

See what share of the issue is reserved for Retail, QIB, NII, and Anchor investors.

Sahajanand Medical Technologies Ltd Registrar & Company Details